2024 has been a pivotal year for Reach Separations, marking a transformative chapter in our…
Subscribe to our Newsletter
CatSci announces strategic acquisition of Reach Separations to offer end-to-end separation science support from discovery to manufacture, with the support of Keensight Capital
CatSci Ltd Acquires Reach Separations CatSci Ltd, an award-winning innovation partner for medicines development, announces…
CatSci Ltd Announce Strategic Partnership with Reach Separations to Offer End-to-End Analytical Support from Discovery to Manufacture
CatSci Ltd, a scientifically-led, commercially-minded and award-winning innovation partner for medicines development, is thrilled to announce…
Reach Separations expands it’s Nottingham premises
We’re expanding! This year Reach Separations has taken a big leap by expanding it’s facilities…
Expert CROs join forces to support drug discovery during the pandemic
Over the last few weeks we have strengthened ties with our neighbours here at Biocity…
Reach Separations has had a face lift!
As the saying goes, ‘a change is as good as a holiday’, and as Reach…
SFC all the way
Peter Ridgway has been invited to present at Biopharma’s Cambridge seminar ‘ADVANCES IN PREPARATIVE SFC…
Developments in 2DLC
Ed Hogarth will be attending Chromsoc’s Multi-Dimensional Chromatography Day at Syngenta on October 29th. The…